Quick Answer
CRESCENT BIOPHARMA, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $10.84 million for the year ending 2025.
- This data is from CRESCENT BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2025 to 2025 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: